Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

beta-N-Acetylhexosaminidases MeSH Descriptor Data 2025


MeSH Heading
beta-N-Acetylhexosaminidases
Tree Number(s)
D08.811.277.450.483.180
Unique ID
D001619
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D001619
Annotation
do not confuse with ACETYLGLUCOSAMINIDASE; /‌defic: consider also TAY SACHS DISEASE and SANDHOFF DISEASE
Scope Note
A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease.
Entry Term(s)
N-Acetyl-beta-D-hexosaminidase
beta-Hexosaminidase
beta-N-Acetyl-D-hexosaminidase
beta-N-Acetyl-hexosaminidase
beta-N-Acetylhexosaminidase
Registry Numbers
EC 3.2.1.52
CAS Type 1 Name
beta-N-Acetyl-D-hexosaminide N-acetylhexosaminohydrolase
Previous Indexing
Glycoside Hydrolases (1966-1970)
Hexosaminidases (1971-1986)
See Also
Sandhoff Disease
Tay-Sachs Disease
Public MeSH Note
2008; see BETA-N-ACETYL-D-HEXOSAMINIDASE 1988-2007
History Note
2008(1988)
Date Established
1987/01/01
Date of Entry
1986/06/02
Revision Date
2007/07/09
beta-N-Acetylhexosaminidases Preferred
page delivered in 0.15s